MarketResearchReports.Biz announces addition of new report “Cancer Symptoms Partnering 2007-2013” to its database
Albany, NY -- (SBWIRE) -- 10/09/2013 -- Cancer Symptoms Partnering 2007-2013
The Cancer Symptoms Partnering 2007-2013 report provides understanding and access to the cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies.
- Trends in solid tumor cancer partnering deals
- Top solid tumor cancer deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type
To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/cancer-symptoms-partnering-2007-2013
The Solid Tumor Cancer Partnering 2007-2013 provides understanding and access to the solid tumor cancer partnering deals and agreements entered into by the worlds leading healthcare companies.
This report provides details of thelatest cancer symptoms agreements announced in the healthcare sectors, covering:
- Oral mucositis
- Cancer pain
- Weight Loss
The report provides an analysis of cancer symptoms partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cancer symptoms technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/176052
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
This data driven report contains over 130 links to online copies of actual cancer symptoms deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
The initial chapters of this report provide an orientation of cancer symptoms partnering trends.
Chapter 1 provides an introduction to the report, whilst
Chapter 2 provides an overview of the trends in cancer symptoms partnering since 2007, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.
Chapter 3 provides an overview of the leading cancer symptoms deals since 2007. Deals are listed by headline value, signed by bigpharma, most active of all pharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/176052
Chapter 4 provides a comprehensive directory of cancer symptoms partnering deals signed and announced since 2007. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of solid tumor cancer technologies and products.
Cancer Symptoms Partnering 2007-2013 is intended to provide the reader with an in-depth understanding and access to cancer symptoms trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
- Trends in cancer symptoms dealmaking in the biopharma industry since 2007
- Access to summary headline, upfront, milestone and royalty data
- Access to over 130 cancer symptoms contract documents
- The leading cancer symptoms deals by value since 2007
Construction in South Africa to 2017: Market Forecast: http://www.marketresearchreports.biz/analysis-details/construction-in-south-africa-to-2017-market-forecast
Timetrics 'Construction in South Africa to 2017: Market Forecast' contains detailed historic and forecast market value data for the construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods.
This report is the result of Timetrics extensive market research covering the construction industry in South Africa. It contains detailed historic and forecast market value data for the construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). 'Construction in South Africa to 2017: Market Forecast' provides a top-level overview and detailed insight into the operating environment of the construction industry in South Africa. It is an essential tool for companies active across the South Africannnn construction value chain and for new players considering to enter the market.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/175870
- Overview of the construction industry in South Africa.
- Historic and forecast market value for the construction industry by construction output and value-add methods for the period 2008 through to 2017.
- Historic and forecast market value by construction activity (new construction, repair and maintenance, refurbishment and demolition) across the construction industry for the period 2008 through to 2017.
Construction in Singapore - Key Trends and Opportunities to 2017: http://www.marketresearchreports.biz/analysis-details/construction-in-singapore-key-trends-and-opportunities-to-2017
This report provides detailed market analysis, information and insights into Singapore's construction market, including:
- The Singapore construction market’s growth prospects by sector, project type and type of construction activity
- Analysis of equipment, material and service costs across each project type within Singapore
- Critical insight into the impact of industry trends and issues and the risks and opportunities they present to participants in Singapore's construction market
- Assessment of the competitive forces facing the construction industry in Singapore and profiles of the leading players
- Data highlights of the largest construction projects in Singapore
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/175524
Singapore’s construction industry recorded a CAGR of 4.14% during the review period (2008?2012). This was supported by public and private investments in Singapore’s infrastructure, commercial and institutional construction markets. Singapore’s construction industry is dominated by infrastructure and residential construction activities, as collectively the infrastructure and residential markets generated 59.6% of the industry’s total value in 2012. The outlook for construction is favorable, due to the government’s focus on country’s infrastructure and residential construction. The construction industry’s output is expected to record a CAGR of 5.04% over the forecast period (2013?2017).
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948